Ziegler AK, Scheele C. Human adipose depots’ diverse functions and dysregulations during cardiometabolic disease. npj metabolic health and disease. 2024;2(1):34. doi:10.1038/s44324-024-00036-zPubMedDOIGoogle Scholar
Holman CD, Sakers AP, Calhoun RP, et al. Aging impairs cold-induced beige adipogenesis and adipocyte metabolic reprogramming. eLife. 2024;12. doi:10.7554/eLife.87756PubMedDOIGoogle Scholar
Mitchell W, Goeminne LJE, Tyshkovskiy A, et al. Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation. eLife. 2024;12. doi:10.7554/eLife.90579Google ScholarPubMedDOI
Chen Z, Ghavimi SAA, Wu M, et al. PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells. JCI insight. 2023;8(24). doi:10.1172/jci.insight.165324Google ScholarPubMedDOI
Kahraman S, Shibue K, De Jesus DF, et al. Fluorescein-based sensors to purify human a-cells for functional and transcriptomic analyses. eLife. 2023;12. doi:10.7554/eLife.85056PubMedDOIGoogle Scholar
Hacken ET, Gruber M, Hernández-Sánchez M, et al. Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing. STAR protocols. 2023;4(4):102165. doi:10.1016/j.xpro.2023.102165Google ScholarPubMedDOI
Guo L, Mohanty A, Singhal S, et al. Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors. iScience. 2023;26(8):107302. doi:10.1016/j.isci.2023.107302PubMedDOIGoogle Scholar
Mansur A, Joseph R, Kim E, et al. Dynamic regulation of inter-organelle communication by ubiquitylation controls skeletal muscle development and disease onset. eLife. 2023;12. doi:10.7554/eLife.81966PubMedDOIGoogle Scholar